よむ、つかう、まなぶ。
資料３－４ 研究報告の報告状況［920KB］ (27 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_70725.html |
| 出典情報 | 薬事審議会 医薬品等安全対策部会（令和7年度第4回 3／6）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
研究報告の報告状況
（2025年8月1日～2025年11月30日）
272 人血清アルブミン
Lin, F. et al.Early human albumin infusion was associated
with 28-day mortality in patients with acute respiratory
failure and hypoalbuminaemia in the intensive care unit: a
retrospective study of the MIMIC-IV database.Respiratory
Medicine. 2025;247:108273-108273.
273 アバコパン
Zhao, Jian-Qun; Guan, Li-Ye; Wang, Zhi-Heng; Yu, ZengFang; Ma, Yin-Ling. Signal mining and analysis of adverse
events associated with avacopan based on FAERS database.
Chinese Journal of New Drugs. 2025; 34(17): 1897-1904.
274
ノルエチステロン・エチニルエストラジ
オール
275 ラモトリギン
タイトル：Combined oral contraceptive administration in
female mice attenuated high-fat diet-induced obesity but not
hepatic inflammation or fibrosis
著者：JANAINA O. CHAVES, GESILY S. AGUIAR, KENIA
M. OLIVEIRA, JOEL A. SILVA JUNIOR, LETICIA S.
FIGUEIREDO, EVERARDO M. CARNEIRO, HELENE
NARA H. BLANC & ROSANE A. RIBEIRO
掲載：Anais da Academia Brasileira de
Ciencias(BRAZIL),Volume:97,Issue:4,e20250004
Hiroshi Bando, et al. Flunitrazepam increases the risk of
lamotrigine-induced cutaneous adverse reactions: Combined
analysis of medical big data and clinical research.Psychiatry
and Clinical Neurosciences, 2020, 79(10), 629-635
D'addona, M.. Distinct immunologic kinetics and
cytomegalovirus reactivation incidence with rituximab-versus
リツキシマブ（遺伝子組換え）［後続２］
276
obinutuzumab-bendamustine in follicular lymphoma: a singleベンダムスチン塩酸塩
center case series study. Journal of Cancer Research and
Clinical Oncology. 2025;151:312:1-14
277 ピロカルピン塩酸塩
Chen, Xiao-Dong; Xiao, Kun-Hong; Wu, Shi-Nan; Wei,
Ming-Yan; Yu, Chao-Feng; Feng, Ke; Cai, Pei-Xin; Wang,
Yu-Ru; Miao, Yan-Liang; Li, Li; Wang, Bo-Zhao; Li, ShiYing; Chen, Qian. Drug-related retinal detachment
pharmacovigilance signals in the real world: evidence from
the FDA Adverse Event Reporting System. Eye (London,
England). 2025.
278 ミフェプリストン・ミソプロストール
Yitina EF, Mihrete GS, Bicha MM, Andualem BS, Addis NA,
Abebe OM, Tolu LB, Lakew AM. Determinants of inductionto-expulsion time and adverse maternal outcomes of second
trimester medical abortion in Amhara Region, Ethiopia:
Prospective follow-up study. Afr J Reprod Health. 2025 Sep
29;29(9s):162-180.
279 スルファメトキサゾール・トリメトプリム
Rinko Lau,Hasti Sadeghi,Fatemeh Ahmadi,Niaz
Chalabianloo,Rebecca Preyra,Mohammad Ali Omrani,and
Flory T. Muanda.Trimethoprim/sulfamethoxazole and risk of
haemophagocytic lymphohistiocytosis (HLH): a literature
review and disproportionality analysis using individual case
safety reports from FAERS.J. Antimicrob. Chemother.
2025;80(9):2421-2427.
27/31
（2025年8月1日～2025年11月30日）
272 人血清アルブミン
Lin, F. et al.Early human albumin infusion was associated
with 28-day mortality in patients with acute respiratory
failure and hypoalbuminaemia in the intensive care unit: a
retrospective study of the MIMIC-IV database.Respiratory
Medicine. 2025;247:108273-108273.
273 アバコパン
Zhao, Jian-Qun; Guan, Li-Ye; Wang, Zhi-Heng; Yu, ZengFang; Ma, Yin-Ling. Signal mining and analysis of adverse
events associated with avacopan based on FAERS database.
Chinese Journal of New Drugs. 2025; 34(17): 1897-1904.
274
ノルエチステロン・エチニルエストラジ
オール
275 ラモトリギン
タイトル：Combined oral contraceptive administration in
female mice attenuated high-fat diet-induced obesity but not
hepatic inflammation or fibrosis
著者：JANAINA O. CHAVES, GESILY S. AGUIAR, KENIA
M. OLIVEIRA, JOEL A. SILVA JUNIOR, LETICIA S.
FIGUEIREDO, EVERARDO M. CARNEIRO, HELENE
NARA H. BLANC & ROSANE A. RIBEIRO
掲載：Anais da Academia Brasileira de
Ciencias(BRAZIL),Volume:97,Issue:4,e20250004
Hiroshi Bando, et al. Flunitrazepam increases the risk of
lamotrigine-induced cutaneous adverse reactions: Combined
analysis of medical big data and clinical research.Psychiatry
and Clinical Neurosciences, 2020, 79(10), 629-635
D'addona, M.. Distinct immunologic kinetics and
cytomegalovirus reactivation incidence with rituximab-versus
リツキシマブ（遺伝子組換え）［後続２］
276
obinutuzumab-bendamustine in follicular lymphoma: a singleベンダムスチン塩酸塩
center case series study. Journal of Cancer Research and
Clinical Oncology. 2025;151:312:1-14
277 ピロカルピン塩酸塩
Chen, Xiao-Dong; Xiao, Kun-Hong; Wu, Shi-Nan; Wei,
Ming-Yan; Yu, Chao-Feng; Feng, Ke; Cai, Pei-Xin; Wang,
Yu-Ru; Miao, Yan-Liang; Li, Li; Wang, Bo-Zhao; Li, ShiYing; Chen, Qian. Drug-related retinal detachment
pharmacovigilance signals in the real world: evidence from
the FDA Adverse Event Reporting System. Eye (London,
England). 2025.
278 ミフェプリストン・ミソプロストール
Yitina EF, Mihrete GS, Bicha MM, Andualem BS, Addis NA,
Abebe OM, Tolu LB, Lakew AM. Determinants of inductionto-expulsion time and adverse maternal outcomes of second
trimester medical abortion in Amhara Region, Ethiopia:
Prospective follow-up study. Afr J Reprod Health. 2025 Sep
29;29(9s):162-180.
279 スルファメトキサゾール・トリメトプリム
Rinko Lau,Hasti Sadeghi,Fatemeh Ahmadi,Niaz
Chalabianloo,Rebecca Preyra,Mohammad Ali Omrani,and
Flory T. Muanda.Trimethoprim/sulfamethoxazole and risk of
haemophagocytic lymphohistiocytosis (HLH): a literature
review and disproportionality analysis using individual case
safety reports from FAERS.J. Antimicrob. Chemother.
2025;80(9):2421-2427.
27/31